STEVIE BAUTISTA: Open Payments
NPI 1881380749 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 43 payments from 14 companies in 2025. Trend: 2023 $338 · 2024 $1,068 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $197 |
| Novartis Pharmaceuticals Corporation | 8 | $183 |
| Alnylam Pharmaceuticals Inc. | 5 | $152 |
| HEARTFLOW, INC. | 6 | $109 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| SCPHARMACEUTICALS INC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Novo Nordisk Inc | 1 | $24 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
Products named: Repatha, LEQVIO, AMVUTTRA, FFRct, FUROSCIX, JARDIANCE, CAMZYOS, Wegovy.
Industry payments across CO — which companies pay providers there.
